Search Results - "Figarella, D."

A French retrospective study on clinical outcome in 102 choroid plexus tumors in children by Siegfried, A., Morin, S., Munzer, C., Delisle, M. B., Gambart, M., Puget, S., Maurage, C. A., Miquel, C., Dufour, C., Leblond, P., André, N., Branger, D. Figarella, Kanold, J., Kemeny, J.-L., Icher, C., Vital, A., Coste, E. Uro, Bertozzi, A. I.

“…The aim of this study was to review and describe therapeutic approaches in children with choroid plexus tumor (CPT) based on a nationwide series. The World…”
Get full text

A polyphenotypic malignant paediatric brain tumour presenting a MN1‐PATZ1 fusion, no epigenetic similarities with CNS High‐Grade Neuroepithelial Tumour with MN1 Alteration (CNS HGNET‐MN1) and related to PATZ1‐fused sarcomas by Burel‐Vandenbos, F., Pierron, G., Thomas, C., Reynaud, S., Gregoire, V., Duhil de Benaze, G., Croze, S., Chivoret, N., Honavar, M., Figarella‐Branger, D., Maurage, C.‐A., Pedeutour, F., Hasselblatt, M., Godfraind, C.

“…Central nervous system high-grade neuroepithelial tumour with MN1 alteration (CNS HGNET-MN1) is a brain tumour methylation class that has recently been…”
Get full text

Outcome analysis of childhood pilocytic astrocytomas: a retrospective study of 148 cases at a single institution by Colin, C., Padovani, L., Chappé, C., Mercurio, S., Scavarda, D., Loundou, A., Frassineti, F., André, N., Bouvier, C., Korshunov, A., Lena, G., Figarella-Branger, D.

“…Background Pilocytic astrocytomas (PAs) are characterized by an excellent prognosis although several factors of adverse outcome have been reported. The…”
Get full text

Identification of variants of the ryanodine receptor type 1 in patients with exertional heat stroke and positive response to the malignant hyperthermia in vitro contracture test by Roux-Buisson, N, Monnier, N, Sagui, E, Abriat, A, Brosset, C, Bendahan, D, Kozak-Ribbens, G, Gazzola, S, Quesada, J.-L., Foutrier-Morello, C, Rendu, J, Figarella-Branger, D, Cozonne, P, Aubert, M, Bourdon, L, Lunardi, J, Fauré, J

Get full text

Primary neurolymphomatosis diagnosis and treatment: A retrospective study by Lagarde, S, Tabouret, E, Matta, M, Franques, J, Attarian, S, Pouget, J, Maues De Paula, A, Figarella-Branger, D, Dory-Lautrec, P, Chinot, O, Barrié, M

“…Abstract Background To discuss the therapeutic approach for primary neurolymphomatosis. Methods We report all primary neurolymphomatosis cases referred to our…”
Get full text

Stereoelectroencephalography in presurgical assessment of MRI-negative epilepsy by McGonigal, Aileen, Bartolomei, Fabrice, Régis, Jean, Guye, Maxime, Gavaret, Martine, Fonseca, Agnès Trébuchon-Da, Dufour, Henry, Figarella-Branger, Dominique, Girard, Nadine, Péragut, Jean-Claude, Chauvel, Patrick

“…According to most existing literature, the absence of an MRI lesion is generally associated with poorer prognosis in resective epilepsy surgery. Delineation of…”
Get full text

Adrenomedullin, an autocrine paracrine factor induced by androgen withdrawal, stimulates 'neuroendocrine phenotype' in LNCaP prostate tumor cells by Berenguer, C, Boudouresque, F, Dussert, C, Daniel, L, Muracciole, X, Grino, M, Rossi, D, Mabrouk, K, Figarella-Branger, D, Martin, P-M, Ouafik, L'Houcine

“…Neuroendocrine (NE) differentiation in prostate cancer (CaP) has been reported to be an early marker associated with the development of androgen independence…”
Get full text

Utility of Ki67 immunostaining in the grading of pineal parenchymal tumours: a multicentre study by Fèvre-Montange, M., Vasiljevic, A., Frappaz, D., Champier, J., Szathmari, A., Aubriot Lorton, M.-H., Chapon, F., Coulon, A., Quintin Roué, I., Delisle, M.-B., Figarella-Branger, D., Laquerrière, A., Miquel, C., Michiels, J.-F., Péoch, M., Polivka, M., Fauchon, F., Jouvet, A.

“…M. Fèvre‐Montange, A. Vasiljevic, D. Frappaz, J. Champier, A. Szathmari, M.‐H. Aubriot Lorton, F. Chapon, A. Coulon, I. Quintin Roué, M.‐B. Delisle, D…”
Get full text

Histomolecular classification of adult diffuse gliomas: The diagnostic value of immunohistochemical markers by Figarella-Branger, D., Maues de Paula, A., Colin, C., Bouvier, C.

“…Adult gliomas are most often infiltrative. The World Health Organization (WHO) has classed them into three major groups according to the presomptive cell of…”
Get full text

Adult intramedullary gliomas by Campello, C, Parker, F, Slimani, S, Le Floch, A, Herbrecht, A, Aghakhani, N, Lacroix, C, Loiseau, H, Lejeune, J P, Perrin, G, Honnorat, J, Dufour, H, Chinot, O, Figarella, D, Bauchet, L, Duffau, H, Lonjon, M, Labauge, P, Messerer, M, Daures, J P, Fabbro, P, Ducot, B

“…Intramedullary gliomas are rare tumors accounting for less than 4% of all primary central nervous system tumors. The aims of this retrospective multicenter…”
Get full text

PL1.1 CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDHmutant gliomas by Appay, R, Dehais, C, Colin, C, Alentorn, A, Carpentier, C, Ducray, F, Ibdaih, A, Kamoun, A, Mokhtari, K, Tabouret, E, Uro-Coste, E, Delattre, J, Figarella-Branger, D

“…Abstract The 2016 WHO classification of the central nervous system tumors stratifies diffuse adult gliomas into three major groups depending on the presence or…”
Get full text

Clear cell ependymoma with trisomy 19 developing bone metastases by Payet, M., Conter, C., Labrousse, F., Maues De Paula, A., Marabelle, A., Figarella Branger, D., Bouvier, R., Frappaz, D.

Get full text

In vitro identification and functional characterization of glial precursor cells in human gliomas by Colin, C., Baeza, N., Tong, S., Bouvier, C., Quilichini, B., Durbec, P., Figarella-Branger, D.

“…Human gliomas including astrocytomas and oligodendrogliomas are defined as being composed of neoplastic astrocytes and oligodendrocytes respectively. Here, on…”
Get full text

KIAA0510, the 3′-untranslated region of the tenascin-R gene, and tenascin-R are overexpressed in pilocytic astrocytomas by El Ayachi, I., Baeza, N., Fernandez, C., Colin, C., Scavarda, D., Pesheva, P., Figarella-Branger, D.

“…I. El Ayachi, N. Baeza, C. Fernandez, C. Colin, D. Scavarda, P. Pesheva and D. Figarella‐Branger (2010) Neuropathology and Applied Neurobiology36, 399–410…”
Get full text

Macrophagic myofasciitis: an emerging entity by Gherardi, RK, Coquet, M, Chérin, P, Authier, F-J, Laforêt, P, Bélec, L, Figarella-Branger, D, Mussini, J-M, Pellissier, J-F, Fardeau, M

“…An unusual inflammatory myopathy characterised by an infiltration of non-epithelioid histiocytic cells has been recorded with increasing frequency in the past…”
Get full text

Fibronectin expression in glioblastomas promotes cell cohesion, collective invasion of basement membrane in vitro and orthotopic tumor growth in mice by Serres, E, Debarbieux, F, Stanchi, F, Maggiorella, L, Grall, D, Turchi, L, Burel-Vandenbos, F, Figarella-Branger, D, Virolle, T, Rougon, G, Van Obberghen-Schilling, E

“…Glioblastoma multiforme (GBM) are highly invasive and angiogenic malignancies with a median survival time from diagnosis of <15 months. Previous work has…”
Get full text

Pituicytomas, a mis-diagnosed benign tumor of the neurohypophysis: report of three cases by FIGARELLA-BRANGER, D, DUFOUR, H, FERNANDEZ, C, BOUVIER-LABIT, C, GRISOLI, F, PELLISSIER, J. F

“…Pituicytoma is a rare benign primary tumor of the neurohypophysis, occurring in the sellar and suprasellar spaces. We report here three new cases with…”
Get full text

Molecular and clinical diversity in primary central nervous system lymphoma by Hernández-Verdin, I., Kirasic, E., Wienand, K., Mokhtari, K., Eimer, S., Loiseau, H., Rousseau, A., Paillassa, J., Ahle, G., Lerintiu, F., Uro-Coste, E., Oberic, L., Figarella-Branger, D., Chinot, O., Gauchotte, G., Taillandier, L., Marolleau, J.-P., Polivka, M., Adam, C., Ursu, R., Schmitt, A., Barillot, N., Nichelli, L., Lozano-Sánchez, F., Ibañez-Juliá, M.-J., Peyre, M., Mathon, B., Abada, Y., Charlotte, F., Davi, F., Stewart, C., de Reyniès, A., Choquet, S., Soussain, C., Houillier, C., Chapuy, B., Hoang-Xuan, K., Alentorn, A.

“…Primary central nervous system lymphoma (PCNSL) is a rare and distinct entity within diffuse large B-cell lymphoma presenting with variable response rates…”
Get full text

Expression of the β chemokines CCL3, CCL4, CCL5 and their receptors in idiopathic inflammatory myopathies by Civatte, M., Bartoli, C., Schleinitz, N., Chetaille, B., Pellissier, J. F., Figarella-Branger, D.

“…The idiopathic inflammatory myopathies (IIM) are a group of autoimmune diseases characterized by chronic lymphocytic and macrophagic infiltration in muscle…”
Get full text

Relevance of combinatorial profiles of intermediate filaments and transcription factors for glioma histogenesis by Colin, C., Virard, I., Baeza, N., Tchoghandjian, A., Fernandez, C., Bouvier, C., Calisti, A., Tong, S., Durbec, P., Figarella-Branger, D.

“…In order to define specific markers for histogenesis of three well‐characterized subgroups of human gliomas (pilocytic astrocytomas, glioblastoma multiforme…”
Get full text